Origin Materials Inc (ORGN)
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
Broken: Primary pillar broken — Achieve Adjusted EBITDA breakeven by 2028: Adjusted EBITDA not reported.
Origin Materials plans to break even on adjusted EBITDA by 2028. The company is working to realign and cut costs. Revenue could grow to $150 million by late 2027. These steps may help the company survive and improve.
The company is losing money and plans to dissolve. Recent layoffs and closures hurt progress. Revenue and profit targets are uncertain. The turnaround may fail and the stock could lose value.
The market expects about 81% revenue growth next year. Our fair value is $2.90, reflecting a cheap valuation versus peers. We see risk from the liquidation plan and weak execution.
Breaks if: Adjusted EBITDA remains negative through 2028
Breaks if: Realignment efforts fail or costs do not decline
Revenue falls below $100 million by 2027-09-30
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround scenario, as the company is currently focused on dissolution and restructuring. The thesis is in a cautious state due to recent weak performance and management volatility.
The market appears to have priced in a low level of fragility, with a valuation that is cheap compared to peers. However, there is an expectations gap indicating that the market anticipates continued challenges ahead.
Fundamentals are likely to remain weak in the near term, with a high probability of missing earnings expectations. Management's focus on workforce reduction and capital allocation may help stabilize cash resources but does not guarantee improved performance.
The long-term thesis hinges on whether ORGN can reverse its course and raise guidance, as well as external factors like inflation and performance of sector leaders. Positive shifts in these areas could provide some support.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
In the next 1 to 3 years, ORGN's situation remains precarious, with significant risks and a focus on liquidation. Not investment advice.